Developmental lineage priming in Dictyostelium by heterogeneous Ras activation
Chattwood, Alex, Nagayama, Koki, Bolourani, Parvin, Harkin, Lauren, Kamjoo, Marzieh, Weeks, Gerald, Thompson, Christopher R L
Published in eLife (26.11.2013)
Published in eLife (26.11.2013)
Get full text
Journal Article
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
ALI, Majid, TELFER, Brian A, CURTIN, Nicola J, WILLIAMS, Kaye J, MCCRUDDEN, Cian, O'ROURKE, Martin, THOMAS, Huw D, KAMJOO, Marzieh, KYLE, Suzanne, ROBSON, Tracy, SHAW, Chris, HIRST, David G
Published in Clinical cancer research (01.10.2009)
Published in Clinical cancer research (01.10.2009)
Get full text
Journal Article
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice
Ali, Majid, Kamjoo, Marzieh, Thomas, Huw D, Kyle, Suzanne, Pavlovska, Ivanda, Babur, Muhammed, Telfer, Brian A, Curtin, Nicola J, Williams, Kaye J
Published in Molecular cancer therapeutics (01.12.2011)
Published in Molecular cancer therapeutics (01.12.2011)
Get full text
Journal Article
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but doesn’t enhance the efficacy of doxorubicin, despite improving tumour perfusion and radiation response in mice
Ali, Majid, Kamjoo, Marzieh, Thomas, Huw D, Kyle, Suzanne, Pavlovska, Ivanda, Babur, Muhammed, Telfer, Brian A, Curtin, Nicola J, Williams, Kaye J
Published in Molecular cancer therapeutics (16.09.2011)
Published in Molecular cancer therapeutics (16.09.2011)
Get full text
Journal Article